miRNAs orchestration of cardiovascular diseases - Particular emphasis on diagnosis, and progression

Elsayed G E Elsakka1, Ahmed I Abulsoud2, Hesham A El-Mahdy1

  • 1Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City, 11231 Cairo, Egypt.

Insights

MicroRNAs (miRNAs) regulate gene expression and are key in heart development and cardiovascular diseases (CVDs). Aberrant miRNAs in cardiac cells signal heart deformities, highlighting their diagnostic and prognostic potential for CVD.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiology

Background:

  • MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression.
  • miRNAs play critical roles in various biological and pathological processes.
  • Altered miRNA expression in cardiac cells is associated with congenital heart defects.

Purpose of the Study:

  • To review the role of miRNAs in the pathophysiology of cardiovascular diseases (CVDs).
  • To explore the potential of miRNAs as diagnostic and prognostic biomarkers for human CVD.
  • To discuss the biological implications of miRNAs in the context of CVD.

Main Methods:

  • Literature review of scientific articles on miRNAs and cardiovascular diseases.
  • Analysis of the function of miRNAs in cardiac cell regulation and disease progression.
  • Evaluation of current research on miRNA biomarkers for CVD diagnosis and prognosis.

Main Results:

  • miRNAs are crucial regulators of gene expression in cardiac cells.
  • Irregular miRNA expression is linked to structural heart deformities.
  • miRNAs show promise as specific biomarkers for diagnosing and monitoring CVDs.

Conclusions:

  • miRNAs are integral to understanding CVD pathophysiology.
  • miRNAs hold significant potential as non-invasive biomarkers for CVD diagnosis and prognosis.
  • Further research into miRNA's biological roles can advance CVD management.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
65
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15